Showing results (11-20 of 394) with videos related to

Sort By:
Pageof 40
Hematology. American Society of Hematology. Education Program|December 6, 2015
Prognostic markers and standard management of chronic lymphocytic leukemiaStephan Stilgenbauer
Blood|October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Blood Advances|June 9, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic LeukemiaJialei Qi, Wen Li, Rashmi Priyadharshini Dheenadayalan, et al.
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Leukemia|July 14, 2019
Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLLDeyan Yordanov Yosifov, Irina Idler, Nupur Bhattacharya, et al.
Hematology. American Society of Hematology. Education Program|January 18, 2011
Understanding and managing ultra high-risk chronic lymphocytic leukemiaStephan Stilgenbauer, Thorsten Zenz
Hematology/Oncology Clinics of North America|August 25, 2004
Molecular genetics and its clinical relevanceStephan Stilgenbauer, Hartmut Döhner
Current Oncology Reports|February 7, 2020
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment ParadigmAnnika Scheffold, Stephan Stilgenbauer
Blood|March 31, 2012
CLL and deletion 13q14: merely the miRs?Daniel Mertens, Stephan Stilgenbauer
Oncotarget|February 15, 2011
Refractory chronic lymphocytic leukemia--new therapeutic strategiesAndrea Schnaiter, Stephan Stilgenbauer
Pageof 40